Structure Info
- Chemspace ID
- CSCS06595022035 (Synthesis)
- IUPAC Name
- (1S,14S)-19-bromo-9,20,21,25-tetramethoxy-15,30-dimethyl-7,23-dioxa-15,30-diazaheptacyclo[22.6.2.2³,⁶.1⁸,¹².1¹⁴,¹⁸.0²⁷,³¹.0²²,³³]hexatriaconta-3,5,8(34),9,11,18,20,22(33),24(32),25,27(31),35-dodecaene
- Mol formula
- C38H41BrN2O6
- Mol weight
- 702 Da
- Catalog Number(s)
- HY-121247, T26911
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 7.25
- Heavy atoms count
- 47
- Rotatable bond count
- 4
- Number of rings
- 7
- Carbon bond saturation, Fsp3
- 0.368
- Polar surface area (Å)
- 62
- Hydrogen bond acceptors count
- 6
- Hydrogen bond donors count
- 0
- Zoom the structure
- CSCS06595022035
Items Overall 5 items from 3 suppliers
Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
---|---|---|---|---|---|---|
Targetmol Chemicals Inc | 30 days | United States To: | 90 | 25 mg | 1,520 | |
Targetmol Chemicals Inc | 30 days | United States To: | 90 | 50 mg | 1,980 | |
Targetmol Chemicals Inc | 30 days | United States To: | 90 | 100 mg | 2,500 | |
Description: Bromotetrandrine is an P-glycoprotein inhibitor, which were developed and coadministered with chemotherapeutic drugs to overcome the effect of efflux pumps thus enhancing the chemosensitivity of therapeutics.; CAS: 62067-29-2 | ||||||
MedChemExpress | TBD | United States To: | 90 | 1 mg | POA | |
Description: Names: Bromotetrandrine; 5-Bromotetrandrine; BrTet; W198; Product Description: Bromotetrandrine is a potent inhibitor of P-glycoprotein (P-gp)-mediated multidrug resistance ( MDR ). Bromotetrandrine shows significant MDR reversal activity in vitro and in vivo, which may be related to the inhibition of P-gp overexpression and the increase in intracellular accumulation of anticancer agents. Bromotetrandrine is a brominated derivative of tetrandrine, which is promising for MDR modulator for tumor assessment .; Target: Drug Derivative;P-glycoprotein; CAS: 62067-29-2 | ||||||
MedChemExpress EU | TBD | Sweden To: | 90 | 1 mg | POA | |
Description: Names: Bromotetrandrine; 5-Bromotetrandrine; BrTet; W198; Product Description: Bromotetrandrine is a potent inhibitor of P-glycoprotein (P-gp)-mediated multidrug resistance (MDR). Bromotetrandrine shows significant MDR reversal activity in vitro and in vivo, which may be related to the inhibition of P-gp overexpression and the increase in intracellular accumulation of anticancer agents. Bromotetrandrine is a brominated derivative of tetrandrine, which is promising for MDR modulator for tumor assessment; Target: Drug Derivative;P-glycoprotein; CAS: 62067-29-2 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire